387 related articles for article (PubMed ID: 29620450)
1. Clinical pharmacogenetics: how do we ensure a favorable future for patients?
Wiltshire T; Dong OM
Pharmacogenomics; 2018 Apr; 19(6):553-562. PubMed ID: 29620450
[TBL] [Abstract][Full Text] [Related]
2. Advancing precision medicine in healthcare: addressing implementation challenges to increase pharmacogenetic testing in the clinical setting.
Dong OM; Wiltshire T
Physiol Genomics; 2017 Jul; 49(7):346-354. PubMed ID: 28550089
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics and big genomic data: from lab to clinic and back again.
Lavertu A; McInnes G; Daneshjou R; Whirl-Carrillo M; Klein TE; Altman RB
Hum Mol Genet; 2018 May; 27(R1):R72-R78. PubMed ID: 29635477
[TBL] [Abstract][Full Text] [Related]
4. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
Hafner S; Haubensak S; Paul T; Zolk O
Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
[No Abstract] [Full Text] [Related]
5. Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.
Borden BA; Lee SM; Danahey K; Galecki P; Patrick-Miller L; Siegler M; Sorrentino MJ; Sacro Y; Davis AM; Rubin DT; Lipstreuer K; Polonsky TS; Nanda R; Harper WR; Koyner JL; Burnet DL; Stadler WM; Kavitt RT; Meltzer DO; Ratain MJ; O'Donnell PH
Pharmacogenomics J; 2019 Dec; 19(6):528-537. PubMed ID: 30713337
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy.
Roosan D; Hwang A; Roosan MR
Pharmacogenomics J; 2021 Feb; 21(1):1-7. PubMed ID: 32843688
[TBL] [Abstract][Full Text] [Related]
7. Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.
Weitzel KW; Cavallari LH; Lesko LJ
Pharm Res; 2017 Aug; 34(8):1551-1555. PubMed ID: 28466392
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics: a general review on progress to date.
Daly AK
Br Med Bull; 2017 Dec; 124(1):65-79. PubMed ID: 29040422
[TBL] [Abstract][Full Text] [Related]
9. Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands.
Bank PCD; Swen JJ; Guchelaar HJ
BMC Med; 2019 Jun; 17(1):110. PubMed ID: 31196067
[TBL] [Abstract][Full Text] [Related]
10. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions.
Reisberg S; Krebs K; Lepamets M; Kals M; Mägi R; Metsalu K; Lauschke VM; Vilo J; Milani L
Genet Med; 2019 Jun; 21(6):1345-1354. PubMed ID: 30327539
[TBL] [Abstract][Full Text] [Related]
11. Clinical and educational impact of pharmacogenomics testing: a case series from the INGENIOUS trial.
Pierson RC; Gufford BT; Desta Z; Eadon MT
Pharmacogenomics; 2017 Jun; 18(9):835-841. PubMed ID: 28594278
[TBL] [Abstract][Full Text] [Related]
12. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.
Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B
Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152
[TBL] [Abstract][Full Text] [Related]
13. Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome.
Roden DM; Van Driest SL; Mosley JD; Wells QS; Robinson JR; Denny JC; Peterson JF
Clin Pharmacol Ther; 2018 May; 103(5):787-794. PubMed ID: 29377064
[TBL] [Abstract][Full Text] [Related]
14. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
[TBL] [Abstract][Full Text] [Related]
15. Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.
Haidar CE; Crews KR; Hoffman JM; Relling MV; Caudle KE
Annu Rev Genomics Hum Genet; 2022 Aug; 23():449-473. PubMed ID: 35537468
[TBL] [Abstract][Full Text] [Related]
16. How to Transition from Single-Gene Pharmacogenetic Testing to Preemptive Panel-Based Testing: A Tutorial.
Marrero RJ; Cicali EJ; Arwood MJ; Eddy E; DeRemer D; Ramnaraign BH; Daily KC; Jones D; Cook KJ; Cavallari LH; Wiisanen Weitzel K; Langaee T; Newsom KJ; Starostik P; Clare-Salzer MJ; Johnson JA; George TJ; Cooper-DeHoff RM
Clin Pharmacol Ther; 2020 Sep; 108(3):557-565. PubMed ID: 32460360
[TBL] [Abstract][Full Text] [Related]
17. Enhancing race-based prescribing precision with pharmacogenomics.
Nguyen A; Desta Z; Flockhart DA
Clin Pharmacol Ther; 2007 Mar; 81(3):323-5. PubMed ID: 17339860
[TBL] [Abstract][Full Text] [Related]
18. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
[TBL] [Abstract][Full Text] [Related]
19. Impact and applicability of pharmacogenomics in rheumatology: an integrated analysis.
Reid P; Danahey K; Lopez Velazquez M; Ratain MJ; O'Donnell PH
Clin Exp Rheumatol; 2021; 39(6):1385-1393. PubMed ID: 33506753
[TBL] [Abstract][Full Text] [Related]
20. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
